Lexicon Pharmaceuticals Value Stock - Dividend - Research Selection
Lexicon Pharmaceuticals
ISIN: US5288723027, WKN: A14SSK
Market price: 4,31 USD
Lexicon Pharmaceuticals Fundamental data and company key figures of the share
| Annual reports in USD | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Key figures | 15-03-2021 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Cash flow | |||||||||||||||||||||||||||||||||||||||||||||||||
| Net operating cash flow | -142.969.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Capital Expenditures | -87.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Free cash flow | -143.056.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Balance sheet | |||||||||||||||||||||||||||||||||||||||||||||||||
| Total Equity | 156.371.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Liabilities & Shareholders equity | 203.788.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Income statement | |||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | -58.574.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Eps (diluted) | -0,530 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted shares outstanding | 110.840.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales/revenue | 23.995.000 | ||||||||||||||||||||||||||||||||||||||||||||||||
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
| Description | Data |
|---|---|
| Symbol | LXRX |
| Market Capitalization | 477.720.384,00 USD |
| Country | |
| Indices | NASDAQ Comp. |
| Sectors | |
| Raw Data Source | US GAAP in Millionen USD |
| Stock Split | 2015-05-21,1.0000/7.0000 |
| Internet | www.lexgen.com |
Description of the company
Lexicon Pharmaceuticals, Inc. (Lexicon Pharmaceuticals) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Lexicon Pharmaceuticals uses its gene knockout technologies and an integrated platform of medical technologies to study the physiological and behavioral functions of almost 5,000 genes in mice and assessed the utility of the proteins encoded by the corresponding human genes as drug targets. It has five drug programs in various stages of clinical development and has advanced small molecule compounds from a number of additional drug programs into various stages of preclinical development and research. Its drug program includes LX4211, LX1032, LX1033, LX2931 and LX7101.